Reinforcing the role of IVIG in DM. ProDERM study. Rohit aggrawal #GCOM22 #myositis

Wonderful and insightful talk by Ingrid and the myositis support groups. Collaboration is key #GCOM22 #myositis

A giant in ILD says MTX is NOT a cause of Chronic fibrosis in ILD. Athol Wells

The Phase 3 trial of Sirolimus (Rapamycin) for the treatment of inclusion body myositis (IBM) has begun! Congratulations, and thanks, to everyone who helped make this happen.

As an editor, I often read discussions that are long winded, meandering and fail to make an impact. They feel like an after-thought rather than a key part of the paper. Here are some tips to make your discussion better. Full credit to Sanjay Saint who taught me this years ago!

#Systematic #review of Mx for anti-#MDA5 #myositis- 15 eligible studies (399 patients). 1. 1 RCT, 3 prospective cohort studies with matched historical controls, 10 retrospective cohort studies,1 retrospective case series were included. Seminars in Arthritis and Rheumatism tinyurl.com/yckemvj3

#ACR22 #ACR2022 12S110. Plenary I Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy

Australian and NZ rheumatologists having FUN #ARA23

The pathogenicity of autoantibodies - Dr Iago Pinal Fernandez #GCOM24

Herbal supplements are not always benign- presented by Deanna Diaz #GCOM24

Long covid causes reduced exercise capacity and more muscle damage with exercise ~ Joome Sun #GCOM #GCOM24 #myositis

Excellent overview from mentor and IBM expert Prof Needham #GCOM #GCOM24 #myositis

CAR T cell promising for refractory myositis. Beware cytokine activation syndrome ~ Georg Schett #GCOM24 #GCOM #myositis

A great first day at the #ARANZRA24 ! At the US workshop with part of the WA team 💪🏼

Excellent talks by Stephen Bird, Julia Martin and our very own WA based Julia Murdoch at the US workshop. Learnt a lot including a practical session on vascular imaging 🧐#ARANZRA24

A year in review! Informative talks by Prof Rebecca Grainger, Prof Eric Morand and Prof Marinka Twilt #ARANZRA . Interspersed with laugh, excellent take home messages!

Morning CTD- ILD session in an MDT format by Prof Mandana Nikpour, Dr Matt Parker and Dr John Mackintosh. Case based discussions and real world management challenges #ARANZRA24 #ARANZRA

What leads to flares of gout? (That’s different to what causes gout in the first place. What triggers it off?) risks: - all types of alcohol - hotter climates, extremes of humidity - animal > veg purines protective: - omega 3 - cherries - but to a limit! Tuhina Neogi, MD, PhD #ARANZRA24

What do you do with MTX in RA-ILD patients? 1. RA dx activity drives RA-ILD 2. MTX is a cornerstone of effective RA therapy 3. MTX not a/w increased RA-ILD 4. MTX pneunonitis is very rare You do the math. Critical for our patients #ARANZRA24

That’s it!!! WA gang! # ARANZRA24